BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30313105)

  • 21. [Treatment strategy for central nervous system involvement in intravascular large B-cell lymphoma].
    Shimada K
    Brain Nerve; 2011 May; 63(5):467-72. PubMed ID: 21515926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ictus cerebellopontine as first manifestation of an intravascular diffuse large B cell lymphoma involving at the kidney].
    Sagüés M; Paredes V; Altés J; Fernández de Sevilla A
    Med Clin (Barc); 2015 Jan; 144(1):48-9. PubMed ID: 24698716
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of intravascular large B-cell lymphoma diagnosed by bone marrow biopsy and FDG-PET scan.
    Takahashi T; Minato M; Tsukuda H; Yoshimoto M; Tsujisaki M
    Intern Med; 2008; 47(10):975-9. PubMed ID: 18480585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis of intravascular lymphoma: usefulness of random skin biopsies].
    Namekawa M; Nakano I
    Brain Nerve; 2011 May; 63(5):451-8. PubMed ID: 21515924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intravascular Large B-cell Lymphoma: a Clinical Analysis of 17 Cases].
    Yang JJ; Chen XC; Tang Y; Shen K; Xie LP; Liu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):145-147. PubMed ID: 29737107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cutaneous intravascular large B-cell lymphoma treated with combination chemotherapy and complicated by rituximab-induced interstitial lung disease.
    Park GH; Kim CH; Chung WK; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    Acta Derm Venereol; 2010 May; 90(3):296-8. PubMed ID: 20526551
    [No Abstract]   [Full Text] [Related]  

  • 28. Primary cutaneous diffuse large B cell lymphoma-other successfully treated by the combination of R-CHOP chemotherapy and surgery: A case report and review of literature.
    Jia J; Li W; Zheng Y
    Medicine (Baltimore); 2017 Feb; 96(8):e6161. PubMed ID: 28225499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
    Evens AM; Kanakry JA; Sehn LH; Kritharis A; Feldman T; Kroll A; Gascoyne RD; Abramson JS; Petrich AM; Hernandez-Ilizaliturri FJ; Al-Mansour Z; Adeimy C; Hemminger J; Bartlett NL; Mato A; Caimi PF; Advani RH; Klein AK; Nabhan C; Smith SM; Fabregas JC; Lossos IS; Press OW; Fenske TS; Friedberg JW; Vose JM; Blum KA
    Am J Hematol; 2015 Sep; 90(9):778-83. PubMed ID: 26044261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neurological disturbances caused by intravascular lymphomatosis].
    Mizutani T
    Brain Nerve; 2011 May; 63(5):443-9. PubMed ID: 21515923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intravascular large B-cell lymphoma: report of a case].
    Yu GH; Qu GM; Yao WD; Lang ZQ; Wang W
    Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):488-9. PubMed ID: 19781202
    [No Abstract]   [Full Text] [Related]  

  • 33. [Asian variant of intravascular large B-cell lymphoma diagnosed by bone marrow biopsy].
    Tadokoro J; Arai Y; Tokita K; Iso H; Nakamura Y; Maki K; Sasaki K; Mitani K
    Rinsho Ketsueki; 2007 Jan; 48(1):61-3. PubMed ID: 17313078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffuse large B-cell lymphoma presenting as a sacral tumor. Report of two cases.
    Liu JK; Kan P; Schmidt MH
    Neurosurg Focus; 2003 Aug; 15(2):E10. PubMed ID: 15350041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi.
    Chiappella A; Tucci A; Castellino A; Pavone V; Baldi I; Carella AM; Orsucci L; Zanni M; Salvi F; Liberati AM; Gaidano G; Bottelli C; Rossini B; Perticone S; De Masi P; Ladetto M; Ciccone G; Palumbo A; Rossi G; Vitolo U;
    Haematologica; 2013 Nov; 98(11):1732-8. PubMed ID: 23812930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravascular Lymphoma: A Diagnostic Challenge.
    Saad EJ; De Goycoechea D; Kurpis M; Albertini RA
    Conn Med; 2017 May; 81(5):281-284. PubMed ID: 29738129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timely Diagnosis and Successful Treatment of Intravascular Large B-Cell Lymphoma in an Elderly Patient with Poor Performance Status.
    Kaito S; Muto H; Miyawaki S; Ohashi K; Tomiyama J
    Am J Case Rep; 2019 Jun; 20():780-784. PubMed ID: 31155607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.
    Récher C; Coiffier B; Haioun C; Molina TJ; Fermé C; Casasnovas O; Thiéblemont C; Bosly A; Laurent G; Morschhauser F; Ghesquières H; Jardin F; Bologna S; Fruchart C; Corront B; Gabarre J; Bonnet C; Janvier M; Canioni D; Jais JP; Salles G; Tilly H;
    Lancet; 2011 Nov; 378(9806):1858-67. PubMed ID: 22118442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly "fit" patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi.
    Merli F; Luminari S; Rossi G; Mammi C; Marcheselli L; Tucci A; Ilariucci F; Chiappella A; Musso M; Di Rocco A; Stelitano C; Alvarez I; Baldini L; Mazza P; Salvi F; Arcari A; Fragasso A; Gobbi PG; Liberati AM; Federico M
    Leuk Lymphoma; 2012 Apr; 53(4):581-8. PubMed ID: 21895543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features and treatment outcomes of intravascular large B-cell lymphoma: a single-center experience in Korea.
    Hong JY; Kim HJ; Ko YH; Choi JY; Jung CW; Kim SJ; Kim WS
    Acta Haematol; 2014; 131(1):18-27. PubMed ID: 24021554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.